Summary:
Centex Studies is conducting a study to evaluate the glycemic effectiveness of once-weekly albiglutide as replacement of prandial insulin in subjects with Type 2 Diabetes receiving basal-bolus insulin therapy.
Qualified Participants Must:
• Be years of age or older
•
Be currently treated with basal-bolus insulin therapy with or without metformin for at least 3 months
Qualified Participants May Receive:
Free study related medical care, for the duration of the trial, Free study related medication and compensation for travel. Please see study personnel for complete details.